ArticleVaccines2024

TLR7 Agonist-Loaded Gadolinium Oxide Nanotubes Promote Anti-Tumor Immunity by Activation of Innate and Adaptive Immune Responses.

Xiupeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.